7,8-Dihydroxy-4-phenylcoumarin
CAS No. 842-01-3
7,8-Dihydroxy-4-phenylcoumarin( —— )
Catalog No. M19166 CAS No. 842-01-3
7,8-Dihydroxy-4-phenylcoumarin inhibits the activity of Staphylococcus aureus DNA helicase
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 41 | In Stock |
|
| 5MG | 36 | In Stock |
|
| 10MG | 48 | In Stock |
|
| 25MG | 68 | In Stock |
|
| 50MG | 86 | In Stock |
|
| 100MG | 119 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 303 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name7,8-Dihydroxy-4-phenylcoumarin
-
NoteResearch use only, not for human use.
-
Brief Description7,8-Dihydroxy-4-phenylcoumarin inhibits the activity of Staphylococcus aureus DNA helicase
-
Description7,8-Dihydroxy-4-phenylcoumarin inhibits the activity of Staphylococcus aureus DNA helicase.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetOpioid Receptor
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number842-01-3
-
Formula Weight254.24
-
Molecular FormulaC15H10O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (393.33 mM)
-
SMILESC1=CC=C(C=C1)C2=CC(=O)OC3=C2C=CC(=C3O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
β-Casomorphin, bovin...
β-Casomorphin, bovine TFA is an opioid peptide isolated from casein peptoneβ-Casomorphin, bovine(beta-casomorphin-7) may contribute significantly to mucin production via a direct effect on intestinal goblet cells and the activation of mu-opioid receptors.?
-
Samidorphan HCl
Samidorphan HCl is an orally active and highly potent modulator of the opioid system that binds to μ‐opioid, κ‐opioid, and delta-opioid receptors.
-
[Nphe1]Nociceptin(1-...
Selective and competitive nociceptin receptor antagonist, devoid of any agonist activity. Binds selectively to recombinant nociceptin receptors (pKi = 8.4), and competitively antagonizes the actions of nociceptin in vitro and in vivo.
Cart
sales@molnova.com